The Philippines' Food and Drug Administration issued a public health warning against the food supplement Toplux Nutrition Astaxanthin + Glutathione Complex because it is unregistered.
Source: Regulatory decision. A decision by a regulator. It covers the uses the regulator reviewed and nothing more.
What was announced
The Philippines' Food and Drug Administration (FDA) warned the public not to purchase or consume Toplux Nutrition Astaxanthin + Glutathione Complex. The FDA stated that the product is unregistered and has no corresponding Certificate of Product Registration (CPR).
The agency cannot assure the quality and safety of unregistered food supplements and food products because they have not gone through the FDA's evaluation process. The manufacture, importation, exportation, sale, offering for sale, distribution, transfer, non-consumer use, promotion, advertising, or sponsorship of health products without proper authorization is prohibited under Republic Act No. 9711, the "Food and Drug Administration Act of 2009".
How it was done
The FDA verified the unregistered status of the product through its online monitoring and post-marketing surveillance.
What happens next
The FDA warned all establishments not to distribute, sell, advertise, or promote the product until a CPR is issued. Regulatory actions and sanctions will be pursued otherwise. The appropriate authorities are requested to ensure the product is not sold in their areas, and the Bureau of Customs is enjoined to restrain its importation and exportation. The product's Market Authorization Holder may petition the FDA for the lifting of this advisory by submitting a formal written request with a copy of the validly issued CPR and photographic evidence of the compliant product.
Where this fits
This news highlights the importance of checking for regulatory approval when considering supplements. Consumers can verify the registration status of food products through the FDA's verification portal to ensure they have undergone evaluation for quality and safety. This specific warning applies to consumers in the Philippines.
Read more: How to choose evidence-based supplements
Who was talking about it
- https://www.fda.gov.ph/ on the news (2026-11-03): The FDA Philippines issued a public health warning. See the post
The source
This is news, reported from the source above. It is not medical advice and not a recommendation. Talk to your doctor or pharmacist before you change any medicine or supplement.